{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T14:58:13Z","timestamp":1783090693648,"version":"3.54.6"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,13]]},"DOI":"10.7759\/cureus.78957","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T20:52:42Z","timestamp":1739479962000},"source":"Crossref","is-referenced-by-count":2,"title":["Intradermal Microdroplet Injection of Standard-Diluted Incobotulinumtoxin A for the Treatment of Erythematotelangiectatic Rosacea: A Study From a Dermatology Center in Medell\u00edn, Colombia"],"prefix":"10.7759","author":[{"given":"Valentina","family":"Dicker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria del Mar","family":"Serna Posada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefania","family":"Galeano Piedrahita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Vasquez Villegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Perez Madrid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S307013","article-title":"Use of botulinum toxin in treating rosacea: a systematic review","volume":"14","author":"Zhang H","year":"2021","unstructured":"Zhang H, Tang K, Wang Y, Fang R, Sun Q. Use of botulinum toxin in treating rosacea: a systematic review. Clin Cosmet Investig Dermatol. 2021, 14:407-17. 10.2147\/CCID.S307013","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref2","article-title":"Botulinum toxin: an effective treatment for flushing and persistent erythema in rosacea","volume":"14","author":"Luque A","year":"2021","unstructured":"Luque A, Rojas AP, Ortiz-Florez A, Perez-Bernal J. Botulinum toxin: an effective treatment for flushing and persistent erythema in rosacea. J Clin Aesthet Dermatol. 2021, 14:42-5.","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2019.1708241","article-title":"The efficacy of intradermal injections of botulinum toxin in the management of enlarged facial pores and seborrhea: a split face-controlled study","volume":"32","author":"Sayed KS","year":"2021","unstructured":"Sayed KS, Hegazy R, Gawdat HI, et al.. The efficacy of intradermal injections of botulinum toxin in the management of enlarged facial pores and seborrhea: a split face-controlled study. J Dermatolog Treat. 2021, 32:771-7. 10.1080\/09546634.2019.1708241","journal-title":"J Dermatolog Treat"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.15962","article-title":"Treating rosacea with botulism toxin: protocol for a systematic review and meta-analysis","volume":"23","author":"He G","year":"2024","unstructured":"He G, Yang Q, Wu J, Huang Y, Zheng H, Cheng H. Treating rosacea with botulism toxin: protocol for a systematic review and meta-analysis. J Cosmet Dermatol. 2024, 23:44-61. 10.1111\/jocd.15962","journal-title":"J Cosmet Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2018.30.6.688","article-title":"A pilot study to evaluate the efficacy and safety of treatment with botulinum toxin in patients with recalcitrant and persistent erythematotelangiectatic rosacea","volume":"30","author":"Park KY","year":"2018","unstructured":"Park KY, Kwon HJ, Kim JM, Jeong GJ, Kim BJ, Seo SJ, Kim MN. A pilot study to evaluate the efficacy and safety of treatment with botulinum toxin in patients with recalcitrant and persistent erythematotelangiectatic rosacea. Ann Dermatol. 2018, 30:688-93. 10.5021\/ad.2018.30.6.688","journal-title":"Ann Dermatol"},{"key":"ref6","article-title":"A new treatment regimen for rosacea: onabotulinumtoxinA","volume":"11","author":"Dayan SH","year":"2012","unstructured":"Dayan SH, Pritzker RN, Arkins JP. A new treatment regimen for rosacea: onabotulinumtoxinA. J Drugs Dermatol. 2012, 11:e76-9.","journal-title":"J Drugs Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-022-00784-0","article-title":"Botulinum toxin A alleviates persistent erythema and Flushing in patients with erythema telangiectasia rosacea","volume":"12","author":"Yang R","year":"2022","unstructured":"Yang R, Liu C, Liu W, Luo J, Cheng S, Mu X. Botulinum toxin A alleviates persistent erythema and Flushing in patients with erythema telangiectasia rosacea. Dermatol Ther (Heidelb). 2022, 12:2285-94. 10.1007\/s13555-022-00784-0","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/PSN.0000000000000121","article-title":"The dilution confusion: easy dosing for botulinum toxins","volume":"36","author":"Bass Kaplan J","year":"2016","unstructured":"Bass Kaplan J. The dilution confusion: easy dosing for botulinum toxins. Plast Surg Nurs. 2016, 36:24-7. 10.1097\/PSN.0000000000000121","journal-title":"Plast Surg Nurs"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.01.048","article-title":"A pilot quality-of-life instrument for acne rosacea","volume":"57","author":"Nicholson K","year":"2007","unstructured":"Nicholson K, Abramova L, Chren MM, Yeung J, Chon SY, Chen SC. A pilot quality-of-life instrument for acne rosacea. J Am Acad Dermatol. 2007, 57:213-21. 10.1016\/j.jaad.2007.01.048","journal-title":"J Am Acad Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.05.044","article-title":"Reliability of clinician erythema assessment grading scale","volume":"71","author":"Tan J","year":"2014","unstructured":"Tan J, Liu H, Leyden JJ, Leoni MJ. Reliability of clinician erythema assessment grading scale. J Am Acad Dermatol. 2014, 71:760-3. 10.1016\/j.jaad.2014.05.044","journal-title":"J Am Acad Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-021-02277-0","article-title":"Role of botulinum toxin A in improving facial erythema and skin quality","volume":"314","author":"Hanna E","year":"2022","unstructured":"Hanna E, Xing L, Taylor JH, Bertucci V. Role of botulinum toxin A in improving facial erythema and skin quality. Arch Dermatol Res. 2022, 314:729-38. 10.1007\/s00403-021-02277-0","journal-title":"Arch Dermatol Res"},{"key":"ref12","article-title":"Cutaneous and ocular rosacea: common and specific physiopathogenic mechanisms and study models","volume":"27","author":"Rodrigues-Braz D","year":"2021","unstructured":"Rodrigues-Braz D, Zhao M, Yesilirmak N, Aractingi S, Behar-Cohen F, Bourges JL. Cutaneous and ocular rosacea: common and specific physiopathogenic mechanisms and study models. Mol Vis. 2021, 27:323-53.","journal-title":"Mol Vis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-011-1179-z","article-title":"Comparison of the spread of three botulinum toxin type A preparations","volume":"304","author":"Kerscher M","year":"2012","unstructured":"Kerscher M, Roll S, Becker A, Wigger-Alberti W. Comparison of the spread of three botulinum toxin type A preparations. Arch Dermatol Res. 2012, 304:155-61. 10.1007\/s00403-011-1179-z","journal-title":"Arch Dermatol Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/toxins9120403","article-title":"Botulinum toxin in the field of dermatology: novel indications","volume":"9","author":"Kim YS","year":"2017","unstructured":"Kim YS, Hong ES, Kim HS. Botulinum toxin in the field of dermatology: novel indications. Toxins (Basel). 2017, 9:10.3390\/toxins9120403","journal-title":"Toxins (Basel)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14692","article-title":"Microbotox: a prospective evaluation of dermatological improvement in patients with mild-to-moderate acne and erythematotelangiectatic rosacea","volume":"21","author":"Calvisi L","year":"2022","unstructured":"Calvisi L, Diaspro A, Sito G. Microbotox: a prospective evaluation of dermatological improvement in patients with mild-to-moderate acne and erythematotelangiectatic rosacea. J Cosmet Dermatol. 2022, 21:3747-53. 10.1111\/jocd.14692","journal-title":"J Cosmet Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2018.12.004","article-title":"Botulinum toxin blocks mast cells and prevents rosacea like inflammation","volume":"93","author":"Choi JE","year":"2019","unstructured":"Choi JE, Werbel T, Wang Z, Wu CC, Yaksh TL, Di Nardo A. Botulinum toxin blocks mast cells and prevents rosacea like inflammation. J Dermatol Sci. 2019, 93:58-64. 10.1016\/j.jdermsci.2018.12.004","journal-title":"J Dermatol Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/325846-intradermal-microdroplet-injection-of-standard-diluted-incobotulinumtoxin-a-for-the-treatment-of-erythematotelangiectatic-rosacea-a-study-from-a-dermatology-center-in-medelln-colombia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T20:52:44Z","timestamp":1739479964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/325846-intradermal-microdroplet-injection-of-standard-diluted-incobotulinumtoxin-a-for-the-treatment-of-erythematotelangiectatic-rosacea-a-study-from-a-dermatology-center-in-medelln-colombia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.78957","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,13]]}}}